GLOBAL CENTERS OF MEDICAL DEVICE TECHNOLOGY: UNITED STATES, EUROPE AND CHINA
Keywords:
medical device, international comparison, economic growth, global marketAbstract
The global market for medical technologies is concentrated in the most advanced countries of the world, namely the U.S.A., Europe and Japan. China is the most important of fast-growing markets. According to some estimates China's global share in 2030 will be as much as 25 %. The aim of the article is to provide an overview of the development of selected economic indicators of medical devices in the regions of the U.S.A., Europe and China. We address the last decade and comment on the estimated future development of these markets. The article is based on selective literature research. Indicators of the market value, global market share, market trends, and export and import values in the three world regions are the key elements of the analysis. We found that U.S. holds about 40 %, the market value (170 billion USD) and Europe holds currently about 30 % of the global market (110 billion USD). The Medtech market in China is about 10 % of global one (53,6 billion USD). The U.S. market growth is about 10 %, the European 5 % and China market shows far largest growth rate about 20-25 % per year. According China will become one of the major player in the Medtech market. The Chinese market, which has focused on low-cost production in the past, is currently coming to the forefront thanks to its development of high-end medical device technology.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 Petra Hospodková
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of the first publication with the work simultaneously licensed under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in CTJ.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website or ResearchGate) prior to and during the submission process, as it can lead to productive exchanges.
CTJ requires that all of the content of the manuscript has been created by its respective authors or that permission to use a copyrighted material has been obtained by the authors before submitting the manuscript to CTJ. CTJ requires that authors have not used any copyrighted material illegally, as for example a picture from another journal or book, a photo, etc. It is the author’s responsibility to use only materials not violating the copyright law. When in doubt, CTJ may ask the authors to supply the pertinent permission or agreement about the use of a copyrighted material.
The opinions expressed in CTJ articles are those of authors and do not necessarily reflect the views of the publishers or the Czech Society for Biomedical Engineering and Medical Informatics.